CD4 and Granuloma: Our results show that both models recapitulate multiple aspects of human HIV and TB infection but that the huDRAG-A2 may offer advantages in terms of higher immune cells (CD4 T cells, macrophages) as well as granulomas with a more classic human pathology, which may be beneficial in the future of co-infection and in studies that depend on the immune response.